Risk of Immune Thrombocytopenic Purpura Recurrence Following Second Measles-Containing Vaccine Dose
Pediatrics
.
2025 Aug 1;156(2):e2025070931.
doi: 10.1542/peds.2025-070931.
Authors
Ousseny Zerbo
1
,
Sharareh Modaressi
1
,
Bruce Fireman
1
,
Pat Ross
1
,
Kristin Goddard
1
,
Jennifer Nelson
2
,
Jason Glanz
3
,
Stephanie A Irving
4
,
Bruno Lewin
5
,
Malini DeSilva
6
,
Simon J Hambidge
7
,
Maria E Sundaram
8
,
Nicola P Klein
1
Affiliations
1
Kaiser Permanente Northern California, Division of Research, Vaccine Study Center, Oakland, California.
2
Kaiser Permanente Washington Health Research Institute, Seattle, Washington.
3
Institute for Health Research, Kaiser Permanente Colorado, Denver, Colorado.
4
The Center for Health Research, Kaiser Permanente Northwest, Portland, Oregon.
5
Department of Research and Evaluation, Kaiser Permanente Southern California, Pasadena, California.
6
HealthPartners Institute, Minneapolis, Minnesota.
7
Ambulatory Care Services, Denver Health, Denver, Colorado.
8
Center for Clinical Epidemiology & Population Health, Marshfield Clinic Research Institute, Marshfield, Wisconsin.
PMID:
40701566
DOI:
10.1542/peds.2025-070931
No abstract available